In Asia Pacific, China is the largest market for blood and blood components due to the increasing geriatric population and rising awareness about blood transfusion. Japan and South Korea are also witnessing steady growth in the market driven by advancements in healthcare technology and increasing government initiatives for blood donation.
Europe, particularly the United Kingdom, Germany, and France, is experiencing significant growth in the blood and blood components market. The presence of well-established healthcare systems and increasing investments in research and development are driving the market growth in these countries. The growing prevalence of blood disorders and the rising demand for blood transfusion are also contributing to the market growth in Europe.